Oncology Today with Dr Neil Love cover image

Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning

Oncology Today with Dr Neil Love

00:00

I Think the E-Cog Trial Is Starting to Look a Little Bit Like Ebrutinib and Retuximab in a 65 Year Old Patient Population

There are 0 t53 mutated mantle cell and foma patients in if you never check for it right there's 10 percent 10 to 15 percent if you look for it and i'm not sure you should be doing this data set or br. If they get covid during maintenance retuximab that could be a problem so uh a lot more questions and answers coming out of triangle  but i'm coming around to the data with more time, he says.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app